Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-23-073229)

Filing Details

Accession Number:: 0001104659-23-073229
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-21 10:57:15
Reporting Period:: 2023-06-09

Accepted Time:: 2023-06-21 10:57:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1508381	Bionik Laboratories Corp.	BNKL	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	271340346

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1716639	Remi Gaston-Dreyfus	C/O Bionik Laboratories Corp. 80 Coolidge Hill Road Watertown MA 02472		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2023-06-09	180,555	$0.60	1,814,871	No	4	P	Indirect	Shares held through GD Holdings and Lombard International Assurance SA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Shares held through GD Holdings and Lombard International Assurance SA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	61,256	Direct

Footnotes

The reporting person acquired the shares of common stock in lieu of cash payment of $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.
Includes 17,476 exchangeable shares of the Issuer's subsidiary.